Genetics of Beta Cell Failure in Mexican Americans
Genetics of Beta Cell Failure in Mexican Americans
批准号:
6829759
负责人:
Thomas A Buchanan
金额:
$136.26万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-01-20 至 2007-12-31
中文摘要
n主要研究项目主管(最后,第一,中间):布坎南,托马斯A.描述:说明申请的广泛,长期目标和具体目的,参考项目的健康关系。简要描述为实现这些目标的研究设计和方法。避免总结过去的成就和使用第一人称。当与应用程序分离时,此摘要旨在作为对所建议工作的简洁而准确的描述。如果该应用程序获得资助,则此描述将成为公共信息。因此,不要包含专有/机密信息。不要超过规定的空间。在怀孕期间发生妊娠期糖尿病(GDM)的年轻西班牙女性中,我们发现相对早发性和进行性胰岛素分泌丧失先于并预测2型糖尿病(T2DM)的发展。胰岛素分泌缺陷似乎是由胰岛素抵抗引起或加重的,并且在GDM先证家族中具有高度遗传性。基于这些观察结果,我们假设存在导致这些年轻女性发生2型糖尿病的胰岛素分泌缺陷的遗传决定因素。我们在西班牙裔美国人的大型队列(包括一个大型家庭队列)中,在详细表型分析以量化胰岛素分泌和胰岛素抵抗方面有丰富的经验。我们也有机会接触到大量有GDM先证者的大家庭。因此,我们建议使用详细的表型分析结合候选基因和全基因组QTL连锁分析来寻找我们已经确定的b细胞缺陷的遗传决定因素。本研究的重点是墨西哥裔美国女性GDM患者及其兄弟姐妹和表亲(即具有b细胞缺陷的家庭)的招募和表型分析,以及在怀孕期间保持正常糖耐量(强大的b细胞功能)的匹配对照女性。所有这些人都将接受详细的b细胞功能、胰岛素敏感性和身体成分研究。其他家庭成员将提供DNA,用于评估血统身份,并用于将来构建GDM先证和匹配对照的单倍型。在此奖励期间,将对GDM和T2DM的候选基因进行研究。对全基因组扫描的支持将单独寻求,随后将对候选区域和基因进行精细的定位和关联研究。最终,该项目的结果对于实现我们的长期目标(a)了解年轻西班牙裔美国人2型糖尿病的根本原因(s)和(b)制定策略,在其演变的相对早期阶段预测和预防该疾病至关重要。网站性能 ======================================== 节结束 ===========================================
英文摘要
n Principal InvestigatodProgram Director (Last, first, middle): Buchanan, Thomas A. DESCRIPTION: State the application's broad, long-term objectives and specific aims, making reference to the health relatedness of the project. Describe concisely the research design and methods for achieving these goals. Avoid summaries of past accomplishments and the use of the first person. This abstract is meant to serve as a succinct and accurate description of the proposed work when separated from the application. If the application is funded, this description, as is, will become public information. Therefore, do not include proprietary/confidential information. DO NOT EXCEED ]HE SPACE PROVIDED. In young Hispanic women who developed gestational diabetes mellitus (GDM) during pregnancy, we have identified relatively early-onset and progressive loss of insulin secretion that precedes and predicts the development of type 2 diabetes mellitus (T2DM). The defect in insulin secretion appears to be caused or worsened by insulin resistance and it is highly heritable in families of GDM probands. Based on these observations, we hypothesize that there are genetic determinants of the defect in insulin secretion that leads to T2DM in these young women. We have extensive experience with the performance of detailed phenotyping to quantify insulin secretion and insulin resistance in large cohorts of Hispanic Americans, including one large family-based cohort. We also have access to a large number of large families with a GDM proband. Accordingly, we propose to search for genetic determinants of the B-cell defect that we have identified, using detailed phenotyping combined with candidate gene and genome-wide QTL linkage analysis. The present proposal is focused on the recruitment and phenotyping of Mexican American women with GDM and their siblings and first cousins (i.e., families enriched with the B-cell defect) and of matched control women who maintained normal glucose tolerance during pregnancy (robust B-cell function). All of these individuals will have detailed studies of B-cell function, insulin sensitivity and body composition. Additional family members will provide DNA for assessment of ideniity-by-descent and for future construction of haplotypes in GDM probands and matched controls. Studies of selected candidate genes for GDM and T2DM will be conducted during this award period. Support for a genome-wide scan will be sought separately and will be followed by fine mapping and association studies of positional candidate regions and genes. Ultimately, the results of this project will be crucial in attaining our long-term goals of (a) understanding the fundamental cause(s) of T2DM in young Hispanic Americans and (b) developing strategies to predict and prevent that disease at relatively early stages in its evolution. PERFORMANCE SITE ========================================Section End===========================================
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Southern California Clinical and Translational Science Institute
-
批准号:10700623
-
项目类别:
-
资助金额:$4.99万
-
财政年份:2023
-
负责人:Thomas A Buchanan
-
依托单位:
Southern California Clinical and Translational Science Institute
-
批准号:10559463
-
项目类别:
-
资助金额:$900.97万
-
财政年份:2016
-
负责人:Thomas A Buchanan
-
依托单位:
Southern California Clinical and Translational Institute
-
批准号:9929249
-
项目类别:
-
资助金额:$53.47万
-
财政年份:2016
-
负责人:Thomas A Buchanan
-
依托单位:
Southern California Clinical and Translational Science Institute
-
批准号:10613592
-
项目类别:
-
资助金额:$919.29万
-
财政年份:2016
-
负责人:Thomas A Buchanan
-
依托单位:
Southern California Clinical and Translational Science Institute
-
批准号:10381374
-
项目类别:
-
资助金额:$283.29万
-
财政年份:2016
-
负责人:Thomas A Buchanan
-
依托单位:
Beta Cell Restoration through Fat Mitigation
-
批准号:9109756
-
项目类别:
-
资助金额:$27.51万
-
财政年份:2011
-
负责人:Thomas A Buchanan
-
依托单位:
Beta Cell Restoration through Fat Mitigation
-
批准号:8897362
-
项目类别:
-
资助金额:$94.42万
-
财政年份:2011
-
负责人:Thomas A Buchanan
-
依托单位:
Beta Cell Restoration through Fat Mitigation
-
批准号:8247932
-
项目类别:
-
资助金额:$68.4万
-
财政年份:2011
-
负责人:Thomas A Buchanan
-
依托单位:
Beta Cell Restoration through Fat Mitigation
-
批准号:8535244
-
项目类别:
-
资助金额:$64.58万
-
财政年份:2011
-
负责人:Thomas A Buchanan
-
依托单位:
Beta Cell Restoration through Fat Mitigation
-
批准号:8703682
-
项目类别:
-
资助金额:$64.58万
-
财政年份:2011
-
负责人:Thomas A Buchanan
-
依托单位:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
-
批准号:8365141
-
项目类别:
-
资助金额:$152.84万
-
财政年份:2011
-
负责人:Thomas A Buchanan
-
依托单位:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
-
批准号:8365140
-
项目类别:
-
资助金额:$152.84万
-
财政年份:2011
-
负责人:Thomas A Buchanan
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8365143
-
项目类别:
-
资助金额:$53.78万
-
财政年份:2011
-
负责人:Thomas A Buchanan
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8365142
-
项目类别:
-
资助金额:$53.78万
-
财政年份:2011
-
负责人:Thomas A Buchanan
-
依托单位:
LOS ANGELES BASIN CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE
-
批准号:8365144
-
项目类别:
-
资助金额:$662.28万
-
财政年份:2011
-
负责人:Thomas A Buchanan
-
依托单位:
Beta Cell Restoration through Fat Mitigation
-
批准号:8336920
-
项目类别:
-
资助金额:$66.56万
-
财政年份:2011
-
负责人:Thomas A Buchanan
-
依托单位:
Los Angeles Basin Clinical and Translational Science Institute
-
批准号:8101318
-
项目类别:
-
资助金额:$1028.84万
-
财政年份:2010
-
负责人:Thomas A Buchanan
-
依托单位:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
-
批准号:8173916
-
项目类别:
-
资助金额:$239.02万
-
财政年份:2010
-
负责人:Thomas A Buchanan
-
依托单位:
Los Angeles Basin Clinical and Translational Science Institute
-
批准号:8101320
-
项目类别:
-
资助金额:$16.42万
-
财政年份:2010
-
负责人:Thomas A Buchanan
-
依托单位:
Southern California Clinical and Translational Science Institute
-
批准号:8655564
-
项目类别:
-
资助金额:$58.26万
-
财政年份:2010
-
负责人:Thomas A Buchanan
-
依托单位:
国内基金
海外基金
登录
查看更多内容
人附睾蛋白4靶向调控TGF beta-smad轴加剧克罗恩病相关肠纤维化进程的作用机制研究
-
批准号:2026JJ82059
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:吴一中
-
依托单位:
AAV介导sTGF-betaRII抑制TGF-beta/Smad2/3信号通路的抗口腔黏膜下纤维化基因治疗研究
-
批准号:JCZRLH202600804
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
AP2B通过WNT/BETA-CATENIN调控颅骨元件成骨活性差异的 分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:孙贤杰
-
依托单位:
Septin9/Tjs/TGF beta 信号作为生物开关调控血脑屏障改善药物渗透性的机制研究
-
批准号:82560050
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2025
-
负责人:蔡婷婷
-
依托单位:
Beta-变换中生存集的Hausdorff维数与拓扑熵研究
-
批准号:12401232
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:肖圆芬
-
依托单位:
改性Beta负载的Mn-M双金属催化剂构筑及催化葡萄糖制2,5-呋喃二甲酸的研究
-
批准号:22402014
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:张微
-
依托单位:
由乙酰氨基葡萄糖高效合成乙酰甘氨酸的AgxO@Sn-beta多活性位催化剂设计及调控
-
批准号:22408032
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:代金杭
-
依托单位:
一株新型野生动物来源Beta冠状病毒鉴定及感染人机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:史卫峰
-
依托单位:
多尺度增强航空用近beta钛合金的微观结构调控及疲劳性能研究
-
批准号:2023JJ40032
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:陈维
-
依托单位:
TGF-beta通路通过降低自噬-基因组稳定性介导胶质母细胞瘤间质亚型替莫唑胺耐药的机制研究
-
批准号:82303919
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈鹭跃
-
依托单位: